John C. Davis Myeloma and Amyloid Program at Tufts Medical Center's Cancer Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
John C. Davis Myeloma And Amyloid Program At Tufts Medical Center’s Cancer Center

John C. Davis Myeloma and Amyloid Program at Tufts Medical Center’s Cancer Center

800 Washington Street
Boston, Massachusetts, United States
Email   Phone   Web  

The John C. Davis Myeloma and Amyloid Program at Tufts Medical Center’s Cancer Center in Downtown Boston is home to some of the world’s top experts in plasma cell disease detection, treatment and research. Funded by a benefactor who is a multiple myeloma patient, it is focused on ensuring that patients with plasma cell diseases such as myeloma or AL Amyloidosis receive excellent up-to-date patient care and treatment, as well as education and personal and family support.

The program is multi-disciplinary in every sense of the word. The team is made up of hematologists who are plasma cell disease experts, stem cell transplant physicians, kidney, orthopedic and heart specialists, experienced pathologists and radiologists, nurses and nurse practitioners and social workers. The expert nurse practitioners and physicians perform all bone marrow studies and have one of the most experienced stem cell transplant laboratory and nursing staffs in the world.

The mission of the John C. Davis Program at Tufts Medical Center is to treat patients in the most effective ways, to care for them and their families, and to advance the treatment and understanding of plasma cell diseases by means of clinical trials and laboratory research. The John C. Davis Program is also home to the Tufts Medical Center Monoclonal Gammopathy of Renal Significance (MGRS) clinic. 

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Raymond L. Comenzo, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close